Is a complete FBLG research report available?

No complete published report is available for FibroBiologics, Inc. (FBLG) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FibroBiologics, Inc. (FBLG)

NASDAQ: FBLG · USD

$0.72

+0.06 (+9.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FBLG analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.9M
Net income (ttm)	-18.7M
EPS (ttm)	-$6.87
Shares out	5.4M
Volume	129,260
Beta	1.17
Price target	$13.5	+1777.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -18.7M
EPS (ttm): -$6.87
Market cap: 3.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FBLG indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001958777
Company name	FibroBiologics, Inc.
Country	United States
Country code	US
Cusip	31573L204
Employees	15
Employees Change	2%
Employees Change Percent	15.38
Enterprise value	$4.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-01-31
Isin	US31573L2043
Last refreshed	2026-07-31
Market cap	$3.9M
Market cap category	Nano-Cap
Price	$0.72
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	FBLG
Website	https://fibrobiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-481.07%
FCF yield	-404.37%
P/B ratio	0.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-18.7M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-123.7
ROCE	-418.3
ROE	-754.7
ROIC	-147.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.09%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.9M
Cash	$1.5M
Current Assets	$2.9M
Current Liabilities	$1.8M
Debt	$2.5M
Debt Equity	$0.95
Equity	$2.6M
Interest Coverage	-82.63
Liabilities	$3.3M
Long Term Assets	$3M
Long Term Liabilities	$1.5M
Net Cash	$-996,000
Net Cash By Market Cap	$-25.65
Net Debt Equity	$0.38
Tangible Book Value	$2.6M
Tangible Book Value Per Share	$0.74
WACC	9.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.59
Net Working Capital	$563,000
Quick ratio	0.81
Working Capital	$1.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-58.66%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.07%
200-day SMA	4.1
50-day SMA	0.89
50-day SMA vs 200-day SMA	50under200
All Time High	1,100
All Time High Change	-99.93%
All Time High Date	2024-01-31
All Time Low	0.62
All Time Low Change	15.98%
All Time Low Date	2026-07-27
ATR	0.07
Beta	1.17
Beta1y	-0.63
Beta2y	0.48
Ch YTD	-84.01
High	0.76
High52	13.16
High52 Date	2025-08-01
High52ch	-94.53%
Low	0.65
Low52	0.62
Low52 Date	2026-07-27
Low52ch	15.98%
Ma50ch	-19.07%
Premarket Change Percent	2.05
Premarket Price	$0.67
Premarket Volume	8,563
Price vs 200-day SMA	-82.47%
RSI	40.39
RSI Monthly	12.34
RSI Weekly	32.23
Sharpe ratio	-1.62x
Sortino ratio	-2.01
Total Return	-58.66%
Tr YTD	-84.01
Tr1m	-9.52%
Tr1w	-2.22%
Tr3m	-45.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$8
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.93
Operating Income	$-17.2M
Price target	$13.5
Price Target Change	$1,777
Price Target Change Top	$1,012

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,741,986%
Float Percent	87.83%
Net Borrowing	1,221,000
Shares Insiders	5.92%
Shares Institutions	11.83%
Shares Out	5,399,112
Shares Qo Q	25.39%
Shares Yo Y	58.66%
Short Float	1.49%
Short Ratio	0.43
Short Shares	1.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.5M
Adjusted OCF	-18,312,000
Average Volume	74,412.1x
Bv Per Share	0.74
CAPEX	$-219,000
Ch1m	-9.52
Ch1w	-2.22
Ch1y	-94.07
Ch3m	-45.1
Ch6m	-89.46
Change	9.87%
Change From Open	8.64
Close	0.65
Days Gap	1.13
Depreciation Amortization	257,000
Dollar Volume	92,963.8
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-17.2M
EBITDA	$-16.3M
EPS	$-6.87
F Score	2
FCF	$-15.7M
FCF EV Yield	-321.83x
FCF Per Share	$-2.91
Financing CF	8,517,000
Fiscal Year End	December
Founded	2,021
Investing CF	-219,000
Ipr	-97.6
Iprfo	-99.88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2026-03-30
Last Split Type	Reverse
Last10k Filing Date	2026-02-24
Ma150	3.2
Ma150ch	-77.55%
Ma20	0.79
Ma20ch	-8.96%
Net CF	-7,185,000
Next Earnings Date	2026-08-11
Open	0.66
Optionable	No
Position In Range	61.25
Post Close	0.72
Postmarket Change Percent	-3.23
Postmarket Price	$0.7
Ppne	2,985,000
Pre Close	0.65
Price Date	2026-07-30
Ptbv Ratio	1.49
Relative Volume	1.76x
Share Based Comp	2,829,000
Tr6m	-89.46%
Us State	Texas
Volume	129,260

FibroBiologics, Inc. (FBLG)

Coverage state: Market snapshot only — no published research

Generate the first FBLG analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FBLG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FBLG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FBLG

Frequently asked questions